PHRX.US Pharmagen Inc

Healthcare Health Care Providers & Services USA Stocks
0.0000 USD
Close of Nov 18, 2025
Market cap
USD 5.17K
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2014.

Is PHRX.US undervalued?

Graham number

The Graham number of Pharmagen Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Pharmagen Inc fundamental analysis

No fundamental analysis for Pharmagen Inc yet.

Pharmagen Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Pharmagen Inc

Pharmagen, Inc. distributes specialty drugs to hospitals, acute care facilities, surgery centers, and other healthcare practitioners in the United States. The company sources and distributes specialty drugs, blood plasma derivatives, specialty products, vaccines, anti-infectives, and hard-to-find pharmaceuticals. It offers plasma derivatives for treating serious medical conditions, such as cancer, hemophilia, rheumatoid arthritis, multiple scleroses, blood disorders, hepatit…

Full company profile